Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Accumulated Depreciation & Amortization (2019 - 2023)

Historic Accumulated Depreciation & Amortization for ADC Therapeutics (ADCT) over the last 3 years, with Q4 2022 value amounting to $344000.0.

  • ADC Therapeutics' Accumulated Depreciation & Amortization rose 16666.67% to $344000.0 in Q4 2022 from the same period last year, while for Dec 2022 it was $344000.0, marking a year-over-year increase of 16666.67%. This contributed to the annual value of $344000.0 for FY2022, which is 16666.67% up from last year.
  • Latest data reveals that ADC Therapeutics reported Accumulated Depreciation & Amortization of $344000.0 as of Q4 2022, which was up 16666.67% from $129000.0 recorded in Q4 2021.
  • ADC Therapeutics' Accumulated Depreciation & Amortization's 5-year high stood at $344000.0 during Q4 2022, with a 5-year trough of $30000.0 in Q4 2019.
  • Over the past 3 years, ADC Therapeutics' median Accumulated Depreciation & Amortization value was $129000.0 (recorded in 2021), while the average stood at $167666.7.
  • Over the last 5 years, ADC Therapeutics' Accumulated Depreciation & Amortization had its largest YoY gain of 16666.67% in 2022, and its largest YoY loss of 16666.67% in 2022.
  • Quarter analysis of 3 years shows ADC Therapeutics' Accumulated Depreciation & Amortization stood at $30000.0 in 2019, then surged by 330.0% to $129000.0 in 2021, then surged by 166.67% to $344000.0 in 2022.
  • Its Accumulated Depreciation & Amortization stands at $344000.0 for Q4 2022, versus $129000.0 for Q4 2021 and $30000.0 for Q4 2019.